Urinary excretion of platelet-activating factor in haemolytic uraemic syndrome.
Since some of the features of haemolytic uraemic syndrome (HUS), such as platelet activation and glomerular injury, could be brought about by platelet-activating factor (PAF), we have studied the urinary excretion of PAF in 10 children with HUS and in 10 healthy age-matched controls. Urinary PAF concentrations, measured by radioimmunoassay, were significantly higher in acute-phase HUS patients than in controls (mean 2.04 [SD 1.66] vs 0.72 [0.43] ng/mg creatinine, p less than 0.05) but were similar to those in controls in samples taken after recovery. High PAF concentrations during the acute phase of HUS may reflect platelet activation and glomerular injury; the lower values after recovery suggest that urinary PAF may be a marker of disease activity.
Benigni
A
A
Division of Nephrology, Ospedali Riuniti Bergamo, Italy.
Boccardo
P
P
Noris
M
M
Remuzzi
G
G
Siegler
R L
RL
D002648:Child; D006463:Hemolytic-Uremic Syndrome / Q000652:urine*; D006801:Humans; D010972:Platelet Activating Factor / Q000652:urine*
D010972:Platelet Activating Factor